| Product NDC: | 54868-5687 |
| Proprietary Name: | Acyclovir |
| Non Proprietary Name: | acyclovir |
| Active Ingredient(s): | 200 mg/5mL & nbsp; acyclovir |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 54868-5687 |
| Labeler Name: | Physicians Total Care, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077026 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20061003 |
| Package NDC: | 54868-5687-0 |
| Package Description: | 473 mL in 1 BOTTLE (54868-5687-0) |
| NDC Code | 54868-5687-0 |
| Proprietary Name | Acyclovir |
| Package Description | 473 mL in 1 BOTTLE (54868-5687-0) |
| Product NDC | 54868-5687 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | acyclovir |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20061003 |
| Marketing Category Name | ANDA |
| Labeler Name | Physicians Total Care, Inc. |
| Substance Name | ACYCLOVIR |
| Strength Number | 200 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |